mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.7 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.7 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |